Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Cerebrovascular Manifestations of Neurosarcoidosis: An Underrecognized Aspect of the Imaging Spectrum
AJNR 39:1194-1200, Bathla, G.,et al, 2018
Prevention of Stroke in Patients with Silent Cerebrovascular Disease
Stroke 48:e44-e71, Smith, E.E.,et al, 2017
Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy
Stroke 42:2410-2418, Plummer, C.,et al, 2011
The "Million Hearts" Initiative - Preventing Heart Attacks and Strokes
NEJM 365:e27, Frieden, T.R.,et al, 2011
Familial Mediterranean Fever and Central Nervous System Involvement: A Case Series
Medicine 89:75-84, Kalyoncu,U.,et al, 2010
Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes: A Systematic Review
Arch Neurol 67:931-940, Neligan,A., et al, 2010
Pediatric Moyamoya Disease: An Analysis of 410 Consecutive Cases
Ann Neurol 68:92-101, Kim,S.-K., et al, 2010
Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009
Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009
Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009
Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease
Stroke 39:497-502, Vergouwen,M.D.I.,et al, 2008
MR Angiography Versus CT Angiography in the Evaluation of Neurovascular Disease
Radiology 245:357-361, Bowen,B.C., 2007
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000
Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000
Clinical Correlates of Vascular Parkinsonism
Arch Neurol 56:98-102, Winikates,J.&Jancovic,J., 1999
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Ischemic Stroke After Surgical Procedure
Neurol 50:895-901, Limburg,M.,et al, 1998
Diabetes Mellitus and the Nervous System
JNNP 65:620-632, Watkins,P.J.&Thomas,P.K., 1998
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Assessment of Digital EEG, Quantitative EEG, and EEG Brain Mapping
Neurol 49:277-292, Nuwer,M., 1997
AIDS and Cerbrovascular Disease
Stroke 27:538-543, Pinto,A.N., 1996
Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996
Gene Therapy for Cerebral Vascular Disease
Stroke 27:1688-1693, Heistad,D.D.&Faraci,F.M., 1996
Cerebrovascular Complications of Fabry's Disease
Ann Neurol 40:8-17, Mitsias,P.&Levine,S.R., 1996
Gait Disorders in Older Adults
J Am Geriatr Soc 44:434-452, Alexander,N.B., 1996
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Undergraduate and Postgraduate Medical Education for Cerebrovascular Disease
Stroke 26:1849-1851, Alberts,M.J., 1995
Neurovascular Manifestations of Heritable Connective Tissue Disorders:A Review
Stroke 25:889-903, Schievink,W.I.,et al, 1994
Review Criteria for Hospital Utilization for Patients with Cerebrovascular Disease
Neurol 44:1531-1532, Lanska,D.J.,et al, 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Transcranial Doppler Sonography
Arch Neurol 51:1054-1056, 10591994., Wechsler,L.R.&Babikian,V.L., 1994
Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994
Differential Diagnosis in Dementia, Principal Components Analysis of Clinical Data From a Population Survey
Arch Neurol 50:72-77, Jorm,A.F.,et al, 1993
Magnetic Resonance Imaging
NEJM 328:708-716, 785-7911993., Edelman,R.R.&Warach,S., 1993
Medicare Hospital Utilization Review for Ischemic Cerebrovascular Disease
Neurol 43:650-654, Lanska,D.J., 1993
Cysticercosis and Cerebrovascular Disease:A Review
JNNP 55:252-254, DelBrutto,O.H., 1992
Advances in Neurology
NEJM 326:1608-1616, 1671-16761992., Gilman,S., 1992
New Magnetic Resonance Techniques for Evaluating Cerebrovascular Disease
Ann Neurol 32:115-122, Fisher,M.,et al, 1992
Magnetic Resonance Angiography, Cerebrovascular Applications
Stroke 23:774-780, Ruggieri,P.M.,et al, 1992
Current Role of Cerebral Angiography in the Diagnosis of Cerebrovascular Diseases
AJR 159:191-197, Wolpert,S.M.&Caplan,L.R., 1992
Neurologic Manifestations of Progressive Systemic Sclerosis
Arch Neurol 49:1292-1295, Averbuch-Heller,L.,et al, 1992
Suicide and Patients with Neurologic Diseases, Methodologic Problems
Arch Neurol 49:1296-1303, Stenager,E.N.&Stenager,E., 1992
Genetice of Cerebrovascular Disease
Stroke 22:276-280, Alberts,M.J., 1991
Cerebral Hemodynamics in Ischemic Cerebrovascular Disease
Ann Neurol 29:231-240, Powers,W.J., 1991
PET:Its Clinical Role in Neurology
JNNP 54:1-5, Brooks,D.J., 1991
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991